Abstract
Mincle, the macrophage-inducible C-type lectin also known as CLEC-4E, binds to the mycobacterial glycolipid trehalose dimycolate and initiates a signaling cascade by serving as a receptor for Mycobacterium tuberculosis and other pathogenic mycobacterial species. Studies of the biological functions of human mincle often rely on mouse models, based on the assumption that the biological properties of the mouse receptor mimic those of the human protein. Experimental support for this assumption has been obtained by expression of the carbohydrate-recognition domain of mouse mincle and characterization of its interaction with small molecule analogs of trehalose dimycolate. The results confirm that the ligand-binding properties of mouse mincle closely parallel those of the human receptor. These findings are consistent with the conservation of key amino acid residues that have been shown to form the ligand-binding site in human and cow mincle. Sequence alignment reveals that these residues are conserved in a wide range of mammalian species, suggesting that mincle has a conserved function in binding ligands that may include endogenous mammalian glycans or pathogen glycans in addition to trehalose dimycolate.
Keywords: glycan-binding receptor, lectin, mycobacteria
1. Introduction
After many years as an orphan receptor, the macrophage inducible C-type lectin, known as mincle or CLEC-4E, has recently been recognized as a receptor for glycans on pathogens [1–3]. It is of particular interest because it can bind to trehalose dimycolate, an unusual glycolipid in the outer wall of mycobacteria. Mincle is a prototype for a novel subgroup of animal glycan-binding receptors, because in addition to containing a Ca2+-dependent carbohydrate-recognition domain (C-type CRD) it initiates signaling in macrophages by interacting with the common Fc receptor γ subunit (FcRγ subunit) [4]. Binding of Syk kinase to the immunotyrosine activation motifs in the cytoplasmic domain of this accessory subunit results in activation of the CARD9 pathway, leading to secretion of inflammatory cytokines including interleukin 6 and tumor necrosis factor α [2,4,5].
A crystal structure of the CRD from cow mincle provides a structural basis for understanding the basis for binding of mincle to trehalose dimycolate [6]. One of the two glucose residues in the trehalose headgroup binds in a primary sugar-binding site that resembles that seen in other C-type CRDs, in which five amino acid side chains coordinate a Ca2+ and simultaneously four of these residues make hydrogen bonds with the 3- and 4-OH groups of the glucose, which is also ligated to the Ca2+. A secondary sugar-binding site interacts with the second glucose residue in trehalose and a hydrophobic groove next to the primary binding site is proposed to accommodate acyl chains attached to the 6-OH group of the glucose residue in the primary binding site. Although structural analysis of human mincle has suggested an alternative arrangement of the binding site [7], recent mutagenesis and binding studies indicate that the arrangement of the binding site in human mincle is likely to resemble closely that seen in the cow structure [8].
Important mycobacterial infections in humans include tuberculosis caused by Mycobacterium tuberculosis and leprosy caused by M. leprae, while M. bovis is the causative agent of the bovine form of tuberculosis [9]. Because of the medical and agricultural importance of these diseases and the potential role of mincle in mediating the interaction between macrophages and mycobacteria, the structure and mechanism of ligand binding by the cow and human proteins have been studied in detail. Although mycobacterial infection is not a common disease of mice, the experimental advantages of working with mice have made it a useful model system. An important advantage of working with mice is the availability of knock-out mice lacking mincle, FcRγ, and other components of the mincle signaling pathway [2,3,10]. In addition, macrophage cell lines from mice, such as RAW 264.7 cells, can be used for in vitro studies of mincle [11]. The applicability of the mouse model to understanding the role of mincle in human disease depends on the conservation of key properties between the human and murine proteins. The studies reported here were undertaken to investigate whether the biochemical properties of the human receptor are faithfully replicated by the mouse protein.
2. Results and Discussion
2.1. Expression of the CRD from Mouse Mincle
Mincle is a type II transmembrane protein, in which the CRD lies at the C-terminal end of the polypeptide (Figure 1A). The goal of these studies was to characterize binding to the CRD by expression of this region as a soluble protein separate from the rest of the polypeptide. In addition, appending a biotinylation tag to the C-terminal end of the polypeptide provides an efficient means of immobilization of the CRD to streptavidin-coated plates (Figure 1B). The region of the polypeptide to be expressed was selected based on previous studies of human mincle (Figure 1C). A cDNA encoding a minimal CRD, which is predicted to contain the three conserved disulfide bonds common to most C-type CRDs, was amplified from a full-length mouse mincle cDNA using primers that included the consensus biotinylation tag at the C-terminus.
The cDNA was inserted into a vector containing the T7 promoter and co-expressed with the biotin ligase gene to ensure efficient attachment of biotin to the lysine residue in the C-terminal tag. Correct folding of C-type CRDs requires both formation of the network of disulfide bonds and binding of Ca2+. Some C-type CRDs, including the CRD from human mincle, have been expressed directly as folded proteins after being directed into the periplasm of bacteria by a prokaryotic signal sequence [12]. In the case of mouse mincle, this strategy did not produce protein in sufficient yield for functional studies, so an alternative approach was employed in which the protein was expressed as inclusion bodies in the cytoplasm of Escherichia coli. Following solubilization of the denatured protein in guanidine hydrochloride, it was refolded by dialysis against Ca2+-containing buffer. The correctly folded protein was selectively purified by affinity chromatography on columns of trehalose-Sepharose, prepared by divinyl sulfone coupling to achieve a high density of immobilized sugar (Figure 2). The presence of some protein in the early fractions suggests that it does not bind tightly to the resin, although a significant amount of the protein is retained sufficiently that it elutes in fraction 10, as the EDTA-containing buffer emerges from the column.
2.2. Binding of Mouse Mincle to Sugar Ligands
A solid phase binding competition assay for quantification of the affinity of mouse mincle for sugar-containing ligand was developed, based on immobilization of the CRD on streptavidin-coated wells. Radioiodinated Man-bovine serum albumin (BSA) was used as a reporter ligand. As shown below, simple monosaccharides are not high affinity ligands for the CRD, binding of Man-BSA can be detected because at a sugar density of approximately 31 mannose residues per protein molecule, the Man-BSA is able to bridge between multiple CRDs immobilized in clusters on the tetrameric streptavidin. When working at concentrations of Man-BSA well below saturation binding, inhibition constants obtained in this assay will correlate closely with dissociation constants [13].
Competition assays comparing α-methyl glucoside and trehalose yielded Ki values of 10.3 ± 1.0 mM and 0.54 ± 0.18 mM (Figure 3), indicating that mincle binds trehalose with roughly 19-fold higher affinity than it binds glucose. This result is very similar to the ratio of 17 obtained for the affinities of human mincle for trehalose and α-methyl glucoside [8] although the absolute affinity of mouse mincle for trehalose is somewhat higher than for human mincle (Ki value of 1.34 ± 0.18 mM). This finding suggests the presence of primary and secondary sugar-binding sites in mouse mincle that closely resemble those in the human protein, an interpretation that is consistent with conservation of the residues that form both of these sites (Figure 1C).
In a further comparison with the human form of mincle, the mouse protein was tested for binding to a series of acylated derivatives of trehalose that serve as simplified, soluble analogs of the natural trehalose dimycolate ligand. These compounds, in which one or both of the 6-OH groups are derivatized with short chain fatty acids, were generated using the ability of the lipase from Candida antarctica to attach short chain acids selectively to primary alcohol groups under anhydrous conditions [15]. Comparison of the Ki values for mono-acyl derivatives shows increasing affinity with increasing chain length up to 10-fold higher affinity than simple trehalose (Figure 4). A similar trend is observed for the di-acyl derivatives and these show significantly enhanced affinity compared to the mono-acyl derivatives. This trend, which is both qualitatively and quantitatively similar to that previously seen for the human protein [8], has been attributed to the presence of a hydrophobic groove adjacent to the 6-OH group of the glucose in the primary binding site in the mincle CRD. The hydrophobic character of the four aliphatic and aromatic residues that form this groove is conserved in the human and mouse proteins (Figure 1C), so the shared ability to bind the glycolipid analogs is consistent with the presence of the groove in both proteins.
A final comparison of the characteristics of human and mouse mincle was made by testing the effect of pH on binding. Binding is maximal above pH 7 and falls of in the range between pH 6 and 7, so that is it reduced to 10% of maximal binding at the pH of intracellular endocytic compartments such as endosomes (Figure 5). Although it has been suggested that mincle probably lacks endocytic activity [2], the pH profile is very similar to that seen for other glycan-binding receptors that recycle through endosomes [16] and it is interesting that the property is retained across species.
2.3. Comparison of Mincle across Species
Based on the combination of previous structural work on the cow protein and mutagenesis of the cow and human proteins, the binding properties have been mapped to specific residues in the CRDs of these proteins, and the present study confirms that mouse mincle, in which these same residues are present, shows conserved binding properties. The strong similarity in the ligand-binding properties of mouse and human mincle suggested that these characteristics might be conserved over a broader range of species. A wider survey of mincle conservation was undertaken, comparing all entries in the National Center for Biotechnology Information database. A total of 62 different sequences that appear to be orthologs of mincle were obtained. Alignment of a selection of these sequences is shown in Figure 6.
In all 62 sequences, there is complete conservation of the residues that form the primary and secondary binding sites as well as conservation of the hydrophobic character of the side chains that make up the hydrophobic groove in cow mincle. Based on the analysis of mouse mincle presented here, in combination with previous work on the human and cow proteins, these findings suggest that the binding properties of mincle are likely to be conserved across these species.
2.4. Discussion
Two key findings emerge from this work regarding comparison of the human and mouse proteins and conservation of mincle across species. The results provide validation of mouse as a model system for studying mincle function in binding trehalose dimycolate. This situation contrasts with the notable lack of conservation of ligand-binding properties in some pathogen-binding receptors, such as DC-SIGN (dendritic cell-intracellular adhesion molecule 1-grabbing nonintegrin), which is one of two closely related receptors in humans, compared to a family of eight closely related genes in mouse, none of which encodes a direct ortholog of the human proteins [17]. From an experimental standpoint, this result provides a basis for extrapolating results with trehalose dimycolate and its analogs obtained in mice, such as the effects of knocking out the mouse gene for mincle, to understanding human biology. Of course, the responses mediated by mincle may still differ as a result of other differences in the immune system between species.
Recent studies of mouse and human mincle in macrophages and in transfected cells indicate that their interactions with some other types of ligands, such as glycerol monomycolate, differ [18]. In these experiments, receptors on cells were exposed to surfaces coated with the ligand, so in addition to possible differences in affinity of the CRDs for these chemically distinct ligands, the differences observed may also be influenced by differences in cell surface density or disposition and interactions with other molecules in the plasma membrane. Nevertheless, the results suggest that biochemical characterization of the interaction of additional types of ligands with the CRDs from human and mouse mincle will be informative.
The demonstration that conserved sequences correlate with conserved functional properties provide a basis for speculation about evolution of mincle function. One important point about the mincle sequences that are available is that mincle orthologs are readily identified across mammalian species, but not beyond this in birds, reptiles or fish. Such selective radiation of some glycan-binding receptors within groups of species has been seen at other levels, such as receptors found in vertebrates but not in invertebrates [19]. The results for mincle suggest that it emerged as a mammalian-specific feature of the adaptive immune response. A further point about mincle evolution relates to the selective pressures that are proposed to drive divergence of the sugar-binding receptors. It has been proposed that rapid divergence of receptors such as DC-SIGN and its homologs in different species has resulted from exposure of these species to different sets of viruses, bacteria and fungi, so that the receptors are adapted in evolutionary time to cope with different pathogens [20,21]. Conservation of ligand-binding properties, as suggested by the work reported here, is more commonly associated with receptors that bind endogenous mammalian glycans, which would not be subject to such evolutionary pressures.
There are several potential explanations for the seemingly unusual evolutionary history of the CRD in mincle. One possibility is that the mycobacterial threat has been persistent across species, so the properties of mincle have been retained. Mycobacterial infections have been reported in a very wide range of species, but for the most part these appear to be a result of infection from humans or other natural hosts and are not self-sustaining infections except in a few species, such as humans and cows [22–24]. It is also notable that such infections have been observed in birds and fish, in which the genomes do not seem to encode mincle orthologs. Another possibility is that the conservation of mincle reflects binding to other ligands, on widely distributed pathogens or on endogenous glycoproteins or glycolipids, and that the binding of mincle represents an opportunistic exploitation of this conserved property of mincle by mycobacterial species. The absence of high affinity binding of both human and mouse mincle to panels of mammalian glycans present on the glycan array created by the Consortium for Functional Glycomics [25] is more consistent with the idea that mincle targets primarily pathogen glycans, but there is also evidence that mincle binds non-glycosylated endogenous ligands such as spliceosome-associated protein 130 released from necrotic cells [4].
3. Experimental Section
3.1. Materials
Sources of material for molecular biology were as follows: a clone of mouse mincle generated by the Integrated Molecular Analysis of Genomes and their Expression (IMAGE) Consortium, Clone 3158063/IRAVp968D122D, with the sequence deposited under accession number BC003218 in the National Center for Biotechnology Information database, was obtained from Source BioScience; synthetic primers, pCR2.1-TOPO cloning vector from Life Technologies (Glasgow, UK); restriction enzymes from New England Biolabs (Hitchin, UK). Trehalose-Sepharose resin for affinity chromatography was prepared by divinyl sulfone coupling [26]. Streptavidin-coated polystyrene wells for the binding assay were from Thermo Scientific Pierce (Loughborough, UK). Man-BSA, obtained from E-Y Laboratories (San Mateo, CA, USA), was iodinated by the chloramine T method (Greenwood and Hunter [27]). Synthesis and characterization of acylated trehalose derivatives has been previously documented [6]. All of these compounds are soluble in water at levels at least 10-fold higher than the concentrations used in the assays.
3.2. Cloning of cDNA for Mouse Mincle
The cDNA for expression of mouse mincle was amplified with Advantage 2 polymerase mix (Takara Bio, Saint-Germain-en-Laye, France) from the IMAGE clone using forward primer aaggatccgatcttggaggatgattaaatggcttgtcctttgaactggaaacattatc, encoding a linker for the expression vector, and reverse primer taaagcttctactcatgccactcgattttctgtgcttcgaagatgtcattcagtccgtccagaggacttatttctggc, encoding the biotinylation tag. The resulting cDNA was purified by agarose gel electrophoresis and cloned into the vector pCR2.1-TOPO (Life Technologies, Glasgow, UK). The sequence was confirmed on an Applied Biosystems 310 genetic analyzer (Foster City, CA, USA). The BamH1-EcoR1 insert was excised and inserted into the vector pT5T [12,28] for expression under the control of phage T7 RNA polymerase.
3.3. Expression of Biotin-Tagged CRD
The expression vector and plasmid pBirA, which encodes biotin ligase and the chloramphenicol resistance gene [29], were transformed into E. coli strain BL21(DE3) and were grown in Luria-Bertani broth in the presence of 50 μg/mL ampicillin and 20 μg/mL chloramphenicol. A 200-mL starter culture grown at 30 °C overnight was used to inoculate 6 L of medium. Growth was continued at 37 °C with shaking until an A550 of 0.7 was reached. Isopropyl-β-d-thiogalactoside was added to a concentration of 100 mg/liter followed by growth for a further 150 min at 37 °C. Bacteria were harvested by centrifuging at 4000× g for 15 min at 4 °C and were washed by resuspending in 10 mM Tris-HCl, pH 7.8 and re-centrifuging and the resulting bacterial pellets were stored frozen.
3.4. Purification of Biotin-Tagged CRD
Frozen bacterial pellets were thawed, suspended in 30 mL of 10 mM Tris-HCl, pH 7.8, and lysed by sonication for four times at full power on a model 250 sonicator (Branson, Danbury, CT, USA) with cooling on ice after each 1-min treatment. The insoluble protein was collected by centrifugation at 10,000× g for 15 min at 4 °C and solubilized by homogenization in 100 mL of 6 M guanidine-HCl containing 100 mM Tris-Cl, pH 7.0 and incubated in the presence of 0.01% 2-mercaptoethanol for 30 min at 4 °C. Following centrifugation for 30 min at 100,000× g, protein was renatured by dialysis against 3 changes of 0.5 M NaCl, 25 mM Tris-Cl, pH 7.8, 25 mM CaCl2 at 4 °C. Insoluble material was removed by centrifugation for 30 min at 30,000× g. The final supernatant was applied to a 10-mL column of trehalose-Sepharose. The column was rinsed with 10 mL of 150 mM NaCl, 25 mM Tris-Cl, pH 7.8, 25 mM CaCl2, the bound protein was eluted with 10 mL of 150 mM NaCl, 25 mM Tris-Cl, pH 7.8, 2.5 mM EDTA. Fractions of 1-mL were collected and aliquots were examined by SDS-polyacrylamide gel electrophoresis to identify those containing the CRD.
3.5. Analytical Methods
SDS-polyacrylamide gel electrophoresis on 17.5% polyacrylamide gels was performed by the method of Laemmli [30]. Streptavidin coated plates were washed once with binding buffer (150 mM NaCl, 25 mM Tris-Cl, pH 7.8, 2.5 mM CaCl2) and were coated with biotin-tagged CRDs at 5 μg/mL in 0.1% (w/v) BSA in binding buffer for 2 h at 4 °C. Wells were washed three times with binding buffer before addition of ligands. Serial 3-fold dilutions of competing ligands were prepared in water, after which buffer and reporter ligand were added to achieve final concentrations of 0.5 μg/mL 125I-Man-BSA and 0.1% BSA in binding buffer. This concentration 125I-Man-BSA is at least 100-fold lower than its Kd, ensuring that the Ki values obtained accurately reflect the affinities of the competing ligands independent of the concentration of the reporter ligand [13]. In the pH-dependence assays, buffers containing 25 mM 2-(N-morpholino)ethanesulfonic acid and 25 mM 3-(N-morpholino)propanesulfonic acid were used in place of the Tris buffer. After incubation for 2 h at 4 °C, wells were washed three times with binding buffer and bound radioactivity was measured in a Wallac WIZARD gamma counter (PerkinElmer Life Sciences, Beaconsfield, UK). Inhibition constants were obtained using SigmaPlot (Systat Software, Hounslow, UK). Values reported are means ± S.D. for 2–3 replicate experiments.
3.6. Sequence Comparisons
Potential mincle orthologs were identified in the protein section of the National Center for Biotechnology Information database [31] by searching with the terms mincle, CLEC4E, and CLECSF9.
4. Conclusions
The results presented here provide evidence that key properties of mincle are conserved between mice and humans. Specifically, the interaction of the CRD with acylated trehalose analogs of trehalose dimycolate shows similar specificity and affinity in the binding site. The results are consistent with the conservation of amino acid residues that form the ligand-binding site in human mincle as well as the cow ortholog. The fact that these residues are conserved across mammalian species suggests that mincle has a conserved function in binding this class of ligands.
Acknowledgments
This work was supported by grant BB/K007718/1 from the Biotechnology and Biological Sciences Research Council, which has also provided funds covering the costs to publish in open access.
Footnotes
Conflicts of Interest
The authors declare no conflict of interest.
Sample Availability: Samples of the expression plamsids are available from the authors, but the synthetic ligands are not available.
References
- 1.Ishikawa E, Ishikawa T, Morita YS, Toyonaga K, Yamada H, Takeuchi O, Kinoshita T, Akira S, Yoshikai Y, Yamasaki S. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J. Exp. Med. 2009;206:2879–2888. doi: 10.1084/jem.20091750. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Wells CA, Savage-Jones CA, Li X, Hitchens K, Butcher S, Murray RZ, Beckhouse AG, Lo Y-L-S, Manzanero S, Cobbold C, et al. The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans. J. Immunol. 2008;180:7404–7413. doi: 10.4049/jimmunol.180.11.7404. [DOI] [PubMed] [Google Scholar]
- 3.Yamasaki S, Matsumoto M, Takeuchi O, Matsuzawa T, Ishikawa E, Sakuma M, Tateno H, Uno J, Hirabayashi J, Mikami Y, et al. C-type lectin Mincle is an activating receptor for pathogenic fungus. Malassezia. Proc. Natl. Acad. Sci. USA. 2009;106:1897–1902. doi: 10.1073/pnas.0805177106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Yamasaki S, Ishikawa E, Sakuma M, Hara H, Ogata K, Saito T. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat. Immunol. 2008;9:1179–1188. doi: 10.1038/ni.1651. [DOI] [PubMed] [Google Scholar]
- 5.Schoenen H, Bodendorfer B, Hitchens K, Manzanero S, Werninghaus K, Nimmerjahn F, Agger EM, Stenger S, Andersen P, Ruland J, et al. Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J. Immunol. 2010;184:2756–2760. doi: 10.4049/jimmunol.0904013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Feinberg H, Jégouzo SAF, Rowntree TJW, Guan Y, Brash MA, Taylor ME, Weis WI, Drickamer K. Mechanism for recognition of an unusual mycobacterial glycolipid by the macrophage receptor mincle. J. Biol. Chem. 2013;288:28457–28465. doi: 10.1074/jbc.M113.497149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Furukawa A, Kamishikiryo J, Mori D, Toyonaga K, Okabe Y, Toji A, Kanda R, Miyake Y, Ose T, Yamasaki S, et al. Structural analysis for glycolipid recognition by the C-type lectins mincle and MCL. Proc. Natl. Acad. Sci. USA. 2013;110:17438–17443. doi: 10.1073/pnas.1312649110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Jégouzo SAF, Harding EC, Acton O, Rex MJ, Fadden AJ, Taylor ME, Drickamer K. Defining the conformation of human mincle that interacts with mycobacterial trehalose dimycolate. Glycobiology. 2014;24:1291–1300. doi: 10.1093/glycob/cwu072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Ashford DA, Whitney E, Raghunathan P, Cosivi O. Epidemiology of selected mycobacteria that infect humans and other animals. Rev. Sci. Tech. 2001;20:325–337. doi: 10.20506/rst.20.1.1266. [DOI] [PubMed] [Google Scholar]
- 10.Werninghaus K, Babiak A, Groß O, Hölscher C, Dietrich H, Agger EM, Mages J, Mocsai A, Schoenen H, Finger K, et al. Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRg-Syk-Card9-dependent innate immune activation. J. Exp. Med. 2009;206:89–97. doi: 10.1084/jem.20081445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Guo M, Härtlova A, Dill BD, Prescott AR, Gierliński M, Trost M. High-resolution quantitative proteome analysis reveals substantial differences between phagosomes of RAW 264.7 and bone marrow derived macrophages. Proteomics. 2014 doi: 10.1002/pmic.201400431. doi:10.1002/pmic.201400431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Taylor ME, Drickamer K. Structure-function analysis of C-type lectins. Methods Enzymol. 2003;363:3–16. doi: 10.1016/S0076-6879(03)01039-5. [DOI] [PubMed] [Google Scholar]
- 13.Levitzki A. Ligand binding. In: Creighton TE, editor. Protein Function: A Practical Approach. Oxford University Press; Oxford, UK: 1997. pp. 101–129. [Google Scholar]
- 14.Stambach NS, Taylor ME. Characterization of carbohydrate recognition by langerin, a C-type lectin of Langerhans cell. Glycobiology. 2003;13:401–410. doi: 10.1093/glycob/cwg045. [DOI] [PubMed] [Google Scholar]
- 15.Park D-W, Kim J-S, Seungjoo-Haam, Kim H-S, Kim W-S. Lipase-catalyzed synthesis of β-methylglucoside esters containing an α-hydroxyl group. Biotechnol. Lett. 2001;23:1947–1952. [Google Scholar]
- 16.Wragg S, Drickamer K. Identification of amino acid residues that determine pH-sensitivity of ligand binding to the asialoglycoprotein receptor. J. Biol. Chem. 1999;274:35400–35406. doi: 10.1074/jbc.274.50.35400. [DOI] [PubMed] [Google Scholar]
- 17.Powlesland AS, Ward EM, Sadhu SK, Guo Y, Taylor ME, Drickamer K. Novel mouse homologs of human DC-SIGN: Widely divergent biochemical properties of the complete set of mouse DC-SIGN-related proteins. J. Biol. Chem. 2006;281:20440–20449. doi: 10.1074/jbc.M601925200. [DOI] [PubMed] [Google Scholar]
- 18.Hattori Y, Morita D, Fujiwara N, Mori D, Nakamura T, Harashima H, Yamasaki S, Sugita M. Glycerol monomycolate is a novel ligand for the human, but not mouse macrophage inducible C-type lectin, mincle. J. Biol. Chem. 2014;289:15405–15412. doi: 10.1074/jbc.M114.566489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Dodd RB, Drickamer K. Lectin-like proteins in model organisms: Implications for evolution of carbohydrate-binding activity. Glycobiology. 2000;11:71R–79R. doi: 10.1093/glycob/11.5.71r. [DOI] [PubMed] [Google Scholar]
- 20.Gagneux P, Varki A. Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology. 1999;9:747–755. doi: 10.1093/glycob/9.8.747. [DOI] [PubMed] [Google Scholar]
- 21.Padler-Karavani V, Hurtado-Ziola N, Chang YC, Sonnenburg JL, Ronaghy A, Yu H, Verhagen A, Nizet V, Chen X, Varki N, et al. Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates. FASEB J. 2014;28:1280–1293. doi: 10.1096/fj.13-241497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.O’Reilly LM, Daborn CJ. The epidemiology of Mycobacterium bovis infections in animals and man: A review. Tuberc. Lung Dis. 1995;76:1–46. doi: 10.1016/0962-8479(95)90591-x. [DOI] [PubMed] [Google Scholar]
- 23.Montali RJ, Mikota SK, Cheng LI. Mycobacterium tuberculosis in zoo and wildlife species. Rev. Sci. Tech. 2001;20:291–303. doi: 10.20506/rst.20.1.1268. [DOI] [PubMed] [Google Scholar]
- 24.Gagneux S. Host–pathogen coevolution in human tuberculosis. Phil. Trans. R. Soc. B. 2012;367:850–859. doi: 10.1098/rstb.2011.0316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Consortium for Functional Glycomics [accessed on 13 March 2015]; Available online: http://www.functionalglycomics.org.
- 26.Fornstedt N, Porath J. Characterization studies on a new lectin found in seed of Vicia ervilia. FEBS Lett. 1975;57:187–191. doi: 10.1016/0014-5793(75)80713-7. [DOI] [PubMed] [Google Scholar]
- 27.Greenwood FC, Hunter WM, Glover JS. The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochem. J. 1963;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 1990;343:341–346. doi: 10.1038/343341a0. [DOI] [PubMed] [Google Scholar]
- 29.Schatz PJ. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: A 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology. 1993;11:1138–1143. doi: 10.1038/nbt1093-1138. [DOI] [PubMed] [Google Scholar]
- 30.Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- 31.National Center for Biotechnology Information [accessed on 10 March 2015]; Available online: http://www.ncbi.nlm.nih.gov.